Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Head and Neck Neoplasms 2Breast Neoplasms 2Neuroendocrine Tumors 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Large B-cell Lymphoma 1Hypoxia 1Glioma 1Carcinoma, Transitional Cell 1

Interventions

Fluorodeoxyglucose F18 2fluciclovine F-18 1atezolizumab 1X-Rays 1Radium-223 1RXDX-106 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Cell Count 1Aminophylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Transitional Cell × Positron Emission Tomography Computed Tomography × Clear all
NCT04018053 2026-01-27

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Brigham and Women's Hospital

Phase EARLY_PHASE1 Active not recruiting
16 enrolled 3 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡